137 related articles for article (PubMed ID: 30715630)
21. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
[TBL] [Abstract][Full Text] [Related]
22. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI
PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.
Mizoguchi M; Nutt CL; Mohapatra G; Louis DN
Brain Pathol; 2004 Oct; 14(4):372-7. PubMed ID: 15605984
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
[TBL] [Abstract][Full Text] [Related]
25. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
Wiencke JK; Zheng S; Jelluma N; Tihan T; Vandenberg S; Tamgüney T; Baumber R; Parsons R; Lamborn KR; Berger MS; Wrensch MR; Haas-Kogan DA; Stokoe D
Neuro Oncol; 2007 Jul; 9(3):271-9. PubMed ID: 17504928
[TBL] [Abstract][Full Text] [Related]
28. Glioblastomas with an oligodendroglial component: a pathological and molecular study.
He J; Mokhtari K; Sanson M; Marie Y; Kujas M; Huguet S; Leuraud P; Capelle L; Delattre JY; Poirier J; Hoang-Xuan K
J Neuropathol Exp Neurol; 2001 Sep; 60(9):863-71. PubMed ID: 11556543
[TBL] [Abstract][Full Text] [Related]
29. Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing.
Su S; Zou JJ; Zeng YY; Cen WC; Zhou W; Liu Y; Su DH; Zhang XL; Huang HY; Lei A; Huang ZH; Jin Y; Li L; Su N; Xie YL; Zhao ZG; Liu JX
Biomed Res Int; 2019; 2019():6096350. PubMed ID: 31781628
[TBL] [Abstract][Full Text] [Related]
30. Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme.
Tunca B; Bekar A; Cecener G; Egeli U; Vatan O; Tolunay S; Kocaeli H; Aksoy K
J Neurooncol; 2007 May; 82(3):263-9. PubMed ID: 17151929
[TBL] [Abstract][Full Text] [Related]
31. mTOR-Dependent Cell Proliferation in the Brain.
Ryskalin L; Lazzeri G; Flaibani M; Biagioni F; Gambardella S; Frati A; Fornai F
Biomed Res Int; 2017; 2017():7082696. PubMed ID: 29259984
[TBL] [Abstract][Full Text] [Related]
32. Early dural metastasis from a case of glioblastoma with primitive neuroectodermal differentiation: A case report and literature review.
Konar SK; Bir SC; Maiti TK; Patra DP; DiPoto Brahmbhatt AC; Jacobsohn JA; Nanda A
J Clin Neurosci; 2017 Jan; 35():78-81. PubMed ID: 28029420
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma with a primitive neuroectodermal component: two cases with implications for glioblastoma cell-of-origin.
Donabedian P; Tuna I; Rahman M; Gregory J; Kresak J; Rees JH
Clin Imaging; 2021 May; 73():139-145. PubMed ID: 33406475
[TBL] [Abstract][Full Text] [Related]
34. Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.
VanderLaan PA; Rangachari D; Mockus SM; Spotlow V; Reddi HV; Malcolm J; Huberman MS; Joseph LJ; Kobayashi SS; Costa DB
Lung Cancer; 2017 Apr; 106():17-21. PubMed ID: 28285689
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
[TBL] [Abstract][Full Text] [Related]
36. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
37. Congenital glioblastoma: a clinicopathologic and genetic analysis.
Brat DJ; Shehata BM; Castellano-Sanchez AA; Hawkins C; Yost RB; Greco C; Mazewski C; Janss A; Ohgaki H; Perry A
Brain Pathol; 2007 Jul; 17(3):276-81. PubMed ID: 17465990
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract][Full Text] [Related]
39. Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins.
Jankowska S; Lewandowska M; Masztalewicz M; Sagan L; Nowacki P; Urasińska E
Pol J Pathol; 2021; 72(1):1-10. PubMed ID: 34060283
[TBL] [Abstract][Full Text] [Related]
40. Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
Vizcaino MA; Palsgrove DN; Yuan M; Giannini C; Cabrera-Aldana EE; Pallavajjala A; Burger PC; Rodriguez FJ
Brain Pathol; 2019 Mar; 29(2):193-204. PubMed ID: 30222900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]